Skip to main content

Kyowa Hakko Kirin

Kyowa Kirin Co., Ltd. is a Japanese specialty pharmaceutical company focused on biotechnology research and development. The company concentrates its operational scope on core therapeutic areas, including nephrology, oncology, immunology, and rare diseases. Its key product offerings feature proprietary monoclonal antibodies and specialty drugs such as burosumab and mogamulizumab. Revenue drivers are primarily sales of proprietary prescription pharmaceuticals across global markets in Japan, North America, and Europe. Kyowa Kirin holds a strong international market position in antibody-based therapeutics. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.

29 of the funds FundTelligence covers report a position in Kyowa Hakko Kirin.

Legal name
Kyowa Hakko Kirin Co LTD
Sector
Health Care
Country
Japan
Funds holding it
29

Funds holding Kyowa Hakko Kirin

Showing the 8 largest of 29 funds holding it.

Loading...